{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-23-000025","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.220610+00:00","generated_at":"2026-06-08T01:58:05.015193+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CEO James Foster buys $1M of CRL stock, terminates sell plan","bullets":["CEO James C. Foster purchased 5,620 shares at average price $178.05 on Nov 14, 2023.","Total purchase price approximately $1.0 million in open market transactions.","Terminated Rule 10b5-1 trading plan dated Feb 24, 2023 that allowed sale of up to 112,341 shares.","Foster cited confidence in strategic direction and long-term growth prospects."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-23-000025","json":"https://secwatch.observer/filing/0001100682-23-000025.json","markdown":"https://secwatch.observer/filing/0001100682-23-000025.md","text":"https://secwatch.observer/filing/0001100682-23-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/0001100682-23-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/crl-20231114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:58:05.015193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}